Literature DB >> 11699638

Mitotic specific phosphorylation of serine-1212 in human DNA topoisomerase IIalpha.

R Ishida1, R Takashima, T Koujin, M Shibata, N Nozaki, M Seto, H Mori, T Haraguchi, Y Hiraoka.   

Abstract

It is known that topoisomerase IIalpha is phosphorylated by several kinases. To elucidate the role of phosphorylation of topoisomerase IIalpha in the cell cycle, we have examined the cell cycle behavior of phosphorylated topoisomerase IIalpha in HeLa cells using antibodies against several phospho-oligopeptides of this enzyme. Here we demonstrate that serine1212 in topoisomerase IIalpha is phosphorylated only in the mitotic phase. Using an antibody against an oligopeptide containing phosphoserine-1212 in topoisomerase IIalpha (PS1212), subcellular localization of topoisomerase IIalpha phosphorylated at serine1212 was examined by indirect immunofluorescence staining, and compared with that of overall topoisomerase IIalpha. Serine1212-phosphorylated topoisomerase IIalpha was localized specifically on mitotic chromosomes, but not on interphase chromosomes; this result contrasts with overall topoisomerase IIalpha which was observed on chomosomes in both interphase and mitosis. Serine1212-phosphorylated topoisomerase lIalpha first appeared on chromosome arms in prophase, became concentrated on the centromeres in metaphase, and disappeared in early telophase. In addition, ICRF-193, a catalytic inhibitor of topoisomerase II, prevented accumulation of serine1212-phosphorylated topoisomerase IIalpha at the centromeres. These results indicate that serine1212 of topoisomerase IIalpha is phosphorylated specifically during mitosis, and suggest that the serine1212-phosphorylated topoisomerase IIalpha acts on resolving topological constraint progressively from the chromosome arm to the centromere during metaphase chromosome condensation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11699638     DOI: 10.1247/csf.26.215

Source DB:  PubMed          Journal:  Cell Struct Funct        ISSN: 0386-7196            Impact factor:   2.212


  10 in total

Review 1.  Topoisomerase II: untangling its contribution at the centromere.

Authors:  Andrew C G Porter; Christine J Farr
Journal:  Chromosome Res       Date:  2004       Impact factor: 5.239

2.  Evolutionary History of TOPIIA Topoisomerases in Animals.

Authors:  Filipa Moreira; Miguel Arenas; Arnaldo Videira; Filipe Pereira
Journal:  J Mol Evol       Date:  2022-02-14       Impact factor: 2.395

Review 3.  The interplay between DNA topoisomerase 2α post-translational modifications and drug resistance.

Authors:  Christophe Lotz; Valérie Lamour
Journal:  Cancer Drug Resist       Date:  2020-02-27

Review 4.  SUMO modification of DNA topoisomerase II: trying to get a CENse of it all.

Authors:  Ming-Ta Lee; Jeff Bachant
Journal:  DNA Repair (Amst)       Date:  2009-02-20

5.  PIASy-dependent SUMOylation regulates DNA topoisomerase IIalpha activity.

Authors:  Hyunju Ryu; Maiko Furuta; Donald Kirkpatrick; Steven P Gygi; Yoshiaki Azuma
Journal:  J Cell Biol       Date:  2010-11-15       Impact factor: 10.539

6.  The impact of the human DNA topoisomerase II C-terminal domain on activity.

Authors:  Emma L Meczes; Kathryn L Gilroy; Katherine L West; Caroline A Austin
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

7.  Casein kinase II-dependent phosphorylation of DNA topoisomerase II suppresses the effect of a catalytic topo II inhibitor, ICRF-193, in fission yeast.

Authors:  Norihiko Nakazawa; Orie Arakawa; Masahiro Ebe; Mitsuhiro Yanagida
Journal:  J Biol Chem       Date:  2019-01-11       Impact factor: 5.157

8.  Structural basis for allosteric regulation of Human Topoisomerase IIα.

Authors:  Arnaud Vanden Broeck; Christophe Lotz; Robert Drillien; Léa Haas; Claire Bedez; Valérie Lamour
Journal:  Nat Commun       Date:  2021-05-20       Impact factor: 14.919

9.  Regulation of the catalytic function of topoisomerase II alpha through association with RNA.

Authors:  Seung-Won Park; Andrew M Parrott; David T Fritz; Yongkyu Park; Michael B Mathews; Chee-Gun Lee
Journal:  Nucleic Acids Res       Date:  2008-09-27       Impact factor: 16.971

10.  The α isoform of topoisomerase II is required for hypercompaction of mitotic chromosomes in human cells.

Authors:  Christine J Farr; Melissa Antoniou-Kourounioti; Michael L Mimmack; Arsen Volkov; Andrew C G Porter
Journal:  Nucleic Acids Res       Date:  2014-01-29       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.